Clinical Trials List
Protocol NumberVEG107200
Not yet recruiting
2006-10-01 - 2008-12-31
Phase I
Terminated1
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
35 participants
